kff employer health benefits survey 2025 glp-1 coverage Among the largest employers (with at least 5,000 workers), 43% now cover GLP -1 weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their cost for the A New Car vs. Health

Gut microbiota-mediated deamidation of NAM is necessary and responsible for the NAD + biosynthesis in various organs, including the kidney, the liver and the colon

- World Anti-Doping Agency

As nutricionistas Amanda Rangel e Marclia Fabri comentam os destaques sobre o uso da inteligncia artificial na nutrio oncolgica, novas tecnologias para avaliao nutricional e a importncia do acompanhamento multiprofissional ao longo do tratamento

Protective MC4R variants identified in the UK Biobank exhibited signaling bias toward -arrestin recruitment and increased MAPK pathway activation suggesting that -arrestin-biased MC4R signaling may represent an effective strategy for weight loss (109, 110)